Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC study.
OBJECTIVE
Previous studies in chronic disease states have demonstrated an association between lower urinary creatinine excretion (UCr) and increased mortality, a finding presumed to reflect the effect of low muscle mass on clinical outcomes. Little is known about the relationship between UCr and other measures of body composition in terms of the ability to predict outcomes of interest.


METHODS
Using data from the Chronic Renal Insufficiency Cohort (CRIC), the relationship between UCr, fat free mass (FFM) as estimated by bioelectrical impedance analysis, and (in a subpopulation) whole-body dual-energy x-ray absorptiometry assessment of appendicular lean mass were characterized. The associations of UCr and FFM with mortality and ESRD were compared using Cox proportional hazards models.


RESULTS
A total of 3604 CRIC participants (91% of the full CRIC cohort) with both a baseline UCr and FFM measurement were included; of these, 232 had contemporaneous dual-energy x-ray absorptiometry measurements. Participants were recruited between July 2003 and March 2007. UCr and FFM were modestly correlated (rho=0.50; P<0.001), while FFM and appendicular lean mass were highly correlated (rho=0.91; P<0.001). Higher urinary urea nitrogen, black race, younger age, and lower serum cystatin C level were all significantly associated with higher UCr. Over a median (interquartile range) of 4.2 (3.1-5.0) years of follow-up, 336 (9.3%) participants died and 510 (14.2%) reached ESRD. Lower UCr was associated with death and ESRD even after adjustment for FFM (adjusted hazard ratio for death per 1 SD higher level of UCr, 0.63 [95% confidence interval, 0.56 to 0.72]; adjusted hazard ratio for ESRD per 1 SD higher level of UCr, 0.70 [95% confidence interval, 0.63 to 0.75]).


CONCLUSIONS
Among a cohort of individuals with CKD, lower UCr is associated with death and ESRD independent of FFM as assessed by bioelectrical impedance analysis.
Due to the number of contributing authors, the affiliations are provided in the Supplemental Material. francis.p.wilson@yale.edu.
F Perry
FP
Wilson
Due to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Dawei
D
Xie
Due to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Amanda H
AH
Anderson
Due to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Mary B
MB
Leonard
Due to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Peter P
PP
Reese
Due to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Patrice
P
Delafontaine
Due to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Edward
E
Horwitz
Due to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Radhakrishna
R
Kallem
Due to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Sankar
S
Navaneethan
Due to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Akinlolu
A
Ojo
Due to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Anna C
AC
Porter
Due to the number of contributing authors, the affiliations are provided in the Supplemental Material.
James H
JH
Sondheimer
Due to the number of contributing authors, the affiliations are provided in the Supplemental Material.
H Lee
HL
Sweeney
Due to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Raymond R
RR
Townsend
Due to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Harold I
HI
Feldman
D015502:Absorptiometry, Photon; D000367:Age Factors; D000368:Aged; D015415:Biomarkers / Q000097:blood / Q000652:urine; D001823:Body Composition; D015331:Cohort Studies; D003404:Creatinine / Q000652:urine*; D055316:Cystatin C / Q000097:blood; D018450:Disease Progression; D017097:Electric Impedance; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000209:etiology; D008297:Male; D008875:Middle Aged; D016016:Proportional Hazards Models; D051436:Renal Insufficiency, Chronic / Q000150:complications / Q000401:mortality* / Q000503:physiopathology*
D015415:Biomarkers; D055316:Cystatin C; D003404:Creatinine
chronic kidney disease; creatinine; end stage kidney disease; end-stage renal disease; mortality